Guselkumab Efficacy in Psoriatic Arthritis Assessed by Multi-Domain Composite Indices: Data from the Phase 3b COSMOS Trial in a TNFi-IR Population

0 views
June 30, 2022
Comments 0
Login to view comments. Click here to Login